Asymmetric biocatalysis of the nerve agent VX by human serum paraoxonase 1: Molecular Docking and Reaction Mechanism calculations
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18450%2F16%3A50005093" target="_blank" >RIV/62690094:18450/16:50005093 - isvavai.cz</a>
Result on the web
<a href="https://link.springer.com/article/10.1007/s00044-016-1704-x" target="_blank" >https://link.springer.com/article/10.1007/s00044-016-1704-x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00044-016-1704-x" target="_blank" >10.1007/s00044-016-1704-x</a>
Alternative languages
Result language
angličtina
Original language name
Asymmetric biocatalysis of the nerve agent VX by human serum paraoxonase 1: Molecular Docking and Reaction Mechanism calculations
Original language description
Organophosphorus compounds have been employed in agricultural activity for a long time, causing serious public health problems. Due to their toxic properties, these compounds have also been used as chemical weapons. In view of this scenario, the catalytic degradation and the development of bioremediation processes of organophosphorus compounds have been of wide interest. Among several enzymes capable of degrading organophosphorus compounds, the human serum paraoxonase 1 has shown good potential for this purpose. To evaluate the interaction mode between the human serum paraoxonase 1 (wild-type and mutants) enzymes and the VX compound, one of the most toxic organophosphorus compounds known, molecular docking calculations were conducted. In addition, seeking to analyze the reaction pathway and the stereochemistry preference by human serum paraoxonase 1 and the Rp and Sp enantiomers of VX, quantum mechanical/molecular mechanics calculations were performed. Our theoretical findings put in evidence that the wild-type and mutant human serum paraoxonase 1 enzymes strongly interact with VX. Moreover, with the quantum mechanical/molecular mechanics study, we observed that the human serum paraoxonase 1 preferentially degrades one enantiomer in relation to the other. The current results indicate key points for designing new, more efficient mutant human serum paraoxonase 1 enzymes for VX degradation.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Medicinal chemistry research
ISSN
1054-2523
e-ISSN
—
Volume of the periodical
25
Issue of the periodical within the volume
11
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
2521-2533
UT code for WoS article
000386763500009
EID of the result in the Scopus database
2-s2.0-84981205697